Treatment Study for Children with Autism Spectrum Disorder
Mental Health & Behavioral Research
What is the purpose of this trial?
The present study examines the impact of Pivotal Response Treatment (PRT) and oxytocin on the development of language, social, and play skills in young children with Autism Spectrum Disorder (ASD). PRT is a well-validated, naturalistic and play-based treatment for children with ASD. All children who participate in this study will receive PRT three times a week at the Yale Child Study Center for 16 weeks. The purpose of this study is to examine the impact of oxytocin as an enhancer of response to PRT. Participants will be randomly assigned to either an oxytocin nasal spray group or a placebo nasal spray group. Neither the research team nor the participants will know or choose which group the participant is assigned to.
- Ages5 - 9 years
- Trial withNational Institute of Mental Health (NIMH)
- Start Date10/31/2018
- End Date08/30/2020
- Last Updated12/10/2018
- Study HIC#2000021581